Remote Decentralized Clinical Trials Could Solve RCT Problems
IMI Project Aims To Establish New Paradigm For Clinical Trials
A new project by Europe’s Innovative Medicines Initiative that is comparing decentralized and traditional clinical trials was launched just before Janssen announced its own decentralized trial.
You may also be interested in...
The COVID-19 pandemic has given a fresh impetus to the ongoing EU project on remote decentralized trials with more appetite for innovative approaches.
Industry has warned that reforming the system for evaluating orphan drugs could have serious consequences for patient access.
Industry has have welcomed another delay to the implementation of drug pricing reforms that aim to lower Canadian drugs prices.